CANF
Can Fite Biopharma Ltd ADR
NYSE MKT: CANF · HEALTHCARE · BIOTECHNOLOGY
$3.10
+3.68% today
Updated 2026-04-30
Market cap
$6.23M
P/E ratio
—
P/S ratio
15.39x
EPS (TTM)
$-10.75
Dividend yield
—
52W range
$3 – $24
Volume
1.4M
Can Fite Biopharma Ltd ADR (CANF) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,489.00%
ROE
-178.20%
ROA
-66.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $745210.00 | $-3.68M | 100.00% | -505.07% | -493.50% |
| 2011 | $468996.00 | $-6.70M | 100.00% | -1,018.32% | -1,428.52% |
| 2012 | — | $-5.57M | — | — | — |
| 2013 | $1.78M | $-8.34M | 100.00% | -503.71% | -467.31% |
| 2014 | $0.00 | $-6.10M | — | — | — |
| 2015 | $164717.00 | $-4.80M | 100.00% | -3,894.56% | -2,912.29% |
| 2016 | $169500.00 | $-6.90M | 100.00% | -5,093.72% | -4,069.33% |
| 2017 | $844746.00 | $-4.97M | 100.00% | -873.13% | -588.18% |
| 2018 | $3.82M | $-6.57M | 100.00% | -141.73% | -172.02% |
| 2019 | $2.03M | $-12.63M | 100.00% | -590.90% | -621.31% |
| 2020 | $763000.00 | $-14.44M | 100.00% | -1,853.08% | -1,892.92% |
| 2021 | $853000.00 | $-12.60M | 100.00% | -1,505.51% | -1,476.55% |
| 2022 | $810000.00 | $-10.24M | 100.00% | -1,246.42% | -1,263.70% |
| 2023 | $743000.00 | $-7.63M | 100.00% | -1,102.96% | -1,027.46% |
| 2024 | $674000.00 | $-7.88M | 100.00% | -1,206.23% | -1,169.14% |
| 2025 | $408212.00 | $-9.91M | 94.07% | -2,456.80% | -2,426.67% |